Literature DB >> 12147789

Elevations of serum phosphorus and potassium in mild to moderate chronic renal insufficiency.

Chi-Yuan Hsu1, Glenn M Chertow.   

Abstract

BACKGROUND: Reduced renal function is associated with a variety of biochemical abnormalities. However, the extent of these changes and their magnitude in relation to renal function is not well defined, especially among individuals with mild to moderate chronic renal insufficiency (CRI).
METHODS: We analysed the Third National Health and Nutrition Examination Survey (NHANES III; 1988-1994) data for 14722 adults aged >/=17 years with measurements of serum creatinine and all electrolytes including ionized calcium. General linear models were used to determine the relationship between mean concentrations of electrolytes and different levels of Cockcroft-Gault creatinine clearance (CrCl). Sample weights were used to produce weighted regression parameters.
RESULTS: Changes in mean serum phosphorus and potassium concentration were evident at relatively modest reductions in CrCl (around 50 to 60 ml/min). Changes in the anion gap and mean levels of ionized calcium and bicarbonate were not apparent until CRI was advanced (CrCl </=20 ml/min). For example, compared with women with CrCl >80 ml/min, those with CrCl 60-50, 50-40, 40-30, 30-20 and </=20 ml/min had mean serum phosphorus concentrations that were higher by 0.1, 0.1, 0.2, 0.3 and 0.8 mg/dl (all P<0.05), and mean serum potassium concentrations that were higher by 0.1, 0.1, 0.1, 0.2 and 0.4 mmol/l (all P<0.05), respectively. These changes were independent of dietary intake and the use of angiotensin converting enzyme (ACE) inhibitors or non-steroidal anti-inflammatory drugs (NSAIDs).
CONCLUSIONS: Increases in serum phosphorus and potassium levels are apparent even among people with mild to moderate CRI. These findings should be broadly generalizable to the larger CRI population in the United States. Subtle elevations in serum phosphorus might contribute to the initiation and maintenance of secondary hyperparathyroidism, which is known to occur in mild to moderate CRI.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12147789     DOI: 10.1093/ndt/17.8.1419

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  24 in total

1.  Estimated GFR, albuminuria, and complications of chronic kidney disease.

Authors:  Lesley A Inker; Josef Coresh; Andrew S Levey; Marcello Tonelli; Paul Muntner
Journal:  J Am Soc Nephrol       Date:  2011-09-30       Impact factor: 10.121

2.  Timing of onset of CKD-related metabolic complications.

Authors:  Olivier Moranne; Marc Froissart; Jerome Rossert; Cedric Gauci; Jean-Jacques Boffa; Jean Philippe Haymann; Mona Ben M'rad; Christian Jacquot; Pascal Houillier; Benedicte Stengel; Bruno Fouqueray
Journal:  J Am Soc Nephrol       Date:  2008-11-12       Impact factor: 10.121

3.  Calcium and phosphate concentrations and future development of type 2 diabetes: the Insulin Resistance Atherosclerosis Study.

Authors:  Carlos Lorenzo; Anthony J Hanley; Marian J Rewers; Steven M Haffner
Journal:  Diabetologia       Date:  2014-04-26       Impact factor: 10.122

4.  Measured GFR does not outperform estimated GFR in predicting CKD-related complications.

Authors:  Chi-yuan Hsu; Kathleen Propert; Dawei Xie; Lee Hamm; Jiang He; Edgar Miller; Akinlolu Ojo; Michael Shlipak; Valerie Teal; Raymond Townsend; Matthew Weir; Jillian Wilson; Harold Feldman
Journal:  J Am Soc Nephrol       Date:  2011-09-15       Impact factor: 10.121

Review 5.  Dietary acid load: a novel nutritional target in chronic kidney disease?

Authors:  Julia J Scialla; Cheryl A M Anderson
Journal:  Adv Chronic Kidney Dis       Date:  2013-03       Impact factor: 3.620

Review 6.  How tubular epithelial cells dictate the rate of renal fibrogenesis?

Authors:  Kevin Louis; Alexandre Hertig
Journal:  World J Nephrol       Date:  2015-07-06

7.  Fibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism.

Authors:  Pieter Evenepoel; Björn Meijers; Liesbeth Viaene; Bert Bammens; Kathleen Claes; Dirk Kuypers; Dirk Vanderschueren; Yves Vanrenterghem
Journal:  Clin J Am Soc Nephrol       Date:  2010-05-06       Impact factor: 8.237

8.  Metabolic abnormalities are present in adults with elevated serum cystatin C.

Authors:  Paul Muntner; Suma Vupputuri; Josef Coresh; Jaime Uribarri; Caroline S Fox
Journal:  Kidney Int       Date:  2009-03-18       Impact factor: 10.612

Review 9.  Consequences and therapy of the metabolic acidosis of chronic kidney disease.

Authors:  Jeffrey A Kraut; Nicolaos E Madias
Journal:  Pediatr Nephrol       Date:  2010-06-05       Impact factor: 3.714

10.  Dietary phosphorus reduction by pretreatment of human breast milk with sevelamer.

Authors:  Elizabeth Ferrara; Jacques Lemire; Vivian M Reznik; Paul C Grimm
Journal:  Pediatr Nephrol       Date:  2004-04-22       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.